Figure 5
Figure 5. Endogenous degradation of CD33 and SOCS3. (A) The adherent monolayer from PBMCs was treated for 2 hours with LPS (100 ng/mL), incubated with α-CD33 (IC7/1) for 1 hour, and cross-linked with GAM for 2 hours. (Ai) Lysates were immunoprecipitated with α-CD33 and immunoblotted with α-CD33 (IC71/3D6). (Aii) Lysates were immunoprecipitated with α-SOCS3 and immunoblotted with α-SOCS3 (M20). (Aiii) WCL was immunoblotted with α-STAT5B as a loading control. (B) Signal intensities of CD33 and SOCS3 expression levels were normalized to signal intensity of STAT5B and are illustrated as graphs.

Endogenous degradation of CD33 and SOCS3. (A) The adherent monolayer from PBMCs was treated for 2 hours with LPS (100 ng/mL), incubated with α-CD33 (IC7/1) for 1 hour, and cross-linked with GAM for 2 hours. (Ai) Lysates were immunoprecipitated with α-CD33 and immunoblotted with α-CD33 (IC71/3D6). (Aii) Lysates were immunoprecipitated with α-SOCS3 and immunoblotted with α-SOCS3 (M20). (Aiii) WCL was immunoblotted with α-STAT5B as a loading control. (B) Signal intensities of CD33 and SOCS3 expression levels were normalized to signal intensity of STAT5B and are illustrated as graphs.

Close Modal

or Create an Account

Close Modal
Close Modal